Vaxcyte (PCVX) Accumulated Expenses (2019 - 2026)
Vaxcyte (PCVX) recorded Accumulated Expenses of $30.62 million in Q3 2026, up 24.5% from $24.59 million a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte reported Accumulated Expenses of $31.07 million, up 6.7% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 52.5% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $29.12 million in FY2024 (-51.3%), $59.82 million in FY2023 (+289.0%), $15.38 million in FY2022 (+75.0%) and $8.79 million in FY2021 (+133.3%).
- Quarterly Accumulated Expenses has ranged from $7.74 million in Q1 2022 to $59.82 million in Q4 2023 over the past five years.
- On a year-over-year basis, Accumulated Expenses rose in four of the last eight quarters, with an average decline of 6.7%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 289.0% in Q4 2023, against a decline of 51.9% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $24.73 million (Q2 2026), $30.25 million (Q1 2026) and $31.07 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 30.62 Mn |
| Jun 30, 2026 | 24.73 Mn |
| Mar 31, 2026 | 30.25 Mn |
| Dec 31, 2025 | 31.07 Mn |
| Sep 30, 2025 | 24.59 Mn |
| Jun 30, 2025 | 32.21 Mn |
| Mar 31, 2025 | 26.04 Mn |
| Dec 31, 2024 | 29.12 Mn |
| Sep 30, 2024 | 30.75 Mn |
| Jun 30, 2024 | 22.15 Mn |
| Mar 31, 2024 | 54.17 Mn |
| Dec 31, 2023 | 59.82 Mn |
| Sep 30, 2023 | 15.02 Mn |
| Jun 30, 2023 | 19.18 Mn |
| Mar 31, 2023 | 18.35 Mn |
| Dec 31, 2022 | 15.38 Mn |
| Sep 30, 2022 | 13.68 Mn |
| Jun 30, 2022 | 9.89 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Dec 31, 2021 | 8.79 Mn |
API Access
Vaxcyte Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();